related E3 ligase, and the other is by glycogen synthase kinase 3 (GSK3β) and another E3 ligase known as betatransducin repeat-containing protein. Following oxidative stress, Keap1 or GSK3β undergoes modification and loses the ability to bind Nrf2; free Nrf2 then translocates to the nucleus and upregulates the expression of downstream anti-oxidative genes. Furthermore, the activity of Nrf2 can be regulated via phosphorylation by protein kinases, such as protein kinase B and C (Cross et al., 1995; Zhang et al., 2013) , and the phosphorylation of Nrf2 affects its binding to Keap1 and its nuclear transportation .
antI-oxIdatIve enzyMes Induced by Inhaled anesthetIc gases
The downstream genes of Nrf2 include four groups of antioxidative enzymes (van Muiswinkel and Kuiperij, 2005; Zhang et al., 2013) . (1) Detoxifying enzymes, including heme oxygenase 1 (HO-1) and NAD(P)H: quinone oxidoreductase 1. (2) Glutathione group, such as glutathione synthetases and glutathione peroxidases. (3) Thioredoxin enzyme group, including thioredoxins, thioredoxin reductases, peroxiredoxins, and sulfiredoxin. (4) Transferase group, such as glutathione S-transferase, sulfotransferase. These enzymes can be induced on purpose by using Nrf2 activators, including some inhaled anesthetic gases (Hoetzel and Schmidt, 2010; Zhao et al., 2013; Lee et al., 2015) .
protectIve effect of Inhaled anesthetIc gases
The inhaled anesthetic gases that are widely applied in clinic settings and in experimental studies include isoflurane, sevoflurane and xenon, especially isoflurane (Zhang et al., 2012 (Zhang et al., , 2014b Hu et al., 2014; Sehba, 2014; Chen et al., 2015a; Cheng et al., 2015; Zuloaga et al., 2015) . Importantly, isoflurane has been reported to reduce the brain injury induced by ischemic stroke (Bickler and Fahlman, 2006; Li and Zuo, 2009; Bedirli et al., 2012; Yin et al., 2014; Sosunov et al., 2015) and hemorrhagic stroke (Gigante et al., 2011; Altay et al., 2012) . Sevoflurane protects the brain against ischemic stroke (Engelhard et al., 2003; Wang et al., 2011 Wang et al., , 2016 Yu et al., 2011; Bedirli et al., 2012; Li et al., 2014) , and hemorrhagic stroke (Karwacki et al., 2005; Lee et al., 2015) . The research on desflurane is limited; however, its protection against ischemia has been reported (Haelewyn et al., 2003) . Xenon protects the brain against traumatic brain injury (TBI) (Harris et al., 2013) and ischemic injury (Dingley et al., 2006; Hobbs et al., 2008; Esencan et al., 2013; Sabir et al., 2014; Liu et al., 2016) .
The inhaled anesthetic gases can be used as either a pre-conditioning approach or a post-conditioning one. Preconditioning has demonstrated protective effects against TBI (Harris et al., 2013; Deng et al., 2014; Khan et al., 2015; Shu et al., 2016) , ischemic stroke (Dingley et al., 2006; Wang et al., 2011 Wang et al., , 2016 Yu et al., 2011; Liu et al., 2013; Shi et al., 2013) , and hemorrhagic stroke (Gigante et al., 2011; Sheng et al., 2012) . Post-conditioning is a relative new concept and it has been reported in ischemic stroke (Li et al., 2014; Yin et al., 2014; Lee et al., 2015; Liu et al., 2016) .
antI-oxIdatIve MechanIsMs of Inhaled anesthetIc gases
The anti-oxidative mechanisms of these inhaled anesthetic gases are not fully understood, especially the ways they activate Nrf2 pathway. Although there are no reports showing that these gases inhibit Keap1, it has been reported that isoflurane, sevoflurane, and desflurane inhibit GSK3β activity and reduce neuronal injury after oxygen-glucose deprivation (Lin et al., 2011) . It seems that activating protein kinases is an important approach for the gases to activate Nrf2 pathway. Both isoflurane and sevoflurane have been reported to activate phosphoinositide 3 kinase (PI3K) and protein kinase B (Akt) (Bickler and Fahlman, 2006; Ye et al., 2012; Zhang et al., 2014a) , and sevoflurane can activate protein kinase C (Lee et al., 2015) . Xenon may activate Nrf2 pathway by phosphorylating Akt and extracellular signal-regulated kinases (Liu et al., 2016) .
clInIcal prospect
It is certain that these inhaled anesthetic gases offer anti-oxidative and neuroprotective effects against TBI and strokes. There are several advantages to use anesthetic gases in clinical settings. They have been used for many years in clinical settings. Moreover, they are safe, fat-soluble with high permeability to blood brain barrier, which are critical for delivery to the brain. In addition, they are routinely given with oxygen, making them preferable and convenient for clinical use, especially in emergent conditions and in operation room. However, several aspects need to be clarified for clinical translation, such as the optimal dose and route for delivery, their protective mechanisms, and the machineries by which they activate Nrf2 pathway and upregulate antioxidative enzymes.
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